US2023357733A1PendingUtilityA1

Reverse Transcriptase and Methods of Use

Assignee: UNIV YALEPriority: Jun 27, 2017Filed: Apr 12, 2023Published: Nov 9, 2023
Est. expiryJun 27, 2037(~10.9 yrs left)· nominal 20-yr term from priority
C12N 9/1276C12P 19/34C12Y 207/07049
73
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides compositions, methods, and kits related to reverse transcriptases derived from E.r. maturase.

Claims

exact text as granted — not AI-modified
1 - 38 . (canceled) 
     
     
         39 . A kit comprising a polypeptide comprising  Eubacterium  rectale (E.r.) maturase or a variant of E.r. maturase, wherein the variant E.r. maturase comprises an amino acid sequence having greater than about 90% identity to the amino acid sequence set forth in SEQ ID NO: 14. 
     
     
         40 . The kit of  claim 39 , further comprising an optimized reaction buffer, wherein the optimized reaction buffer comprises Tris or HEPES, KCl, MgCl 2 , and DTT.

Join the waitlist — get patent alerts

Track US2023357733A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.